FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/06/089354 [Registered on: 23/06/2025] Trial Registered Prospectively
Last Modified On: 03/06/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Diagnostic
Preventive 
Study Design  Other 
Public Title of Study   Ayurveda Treatment Protocol In Improving Visual Acuity In Dry Age-Related Macular Degeneration 
Scientific Title of Study   Effectiveness Of Selected Ayurveda Treatment Protocol In Improving Visual Acuity In Dry Age-Related Macular Degeneration 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Anjana Saji 
Designation  PG Scholar, Department Of Shalakyathanthra, Room no. 105, Government ayurveda college, Trivandrum 
Affiliation  Government Ayurveda College, Trivandrum 
Address  Sreenilayam, Vattathamara P.O, Kadakkal, Kollam

Thiruvananthapuram
KERALA
691536
India 
Phone  8590904006  
Fax    
Email  anjanasajikmr@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr. S Sunilkumar 
Designation  HOD, Department of Shalakyathanthra, Room no.105, Govt. Ayurveda College, Trivandrum 
Affiliation  Government Ayurveda College, Trivandrum 
Address  Anjanam, Edakulangara P.O, Kollam

Kollam
KERALA
691536
India 
Phone  8590904006  
Fax    
Email  drsunilsalakya@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Anjana Saji 
Designation  PG Scholar, Department Of Shalakyathanthra, Room No. 105, Government Ayurveda College, Trivandrum 
Affiliation  Government Ayurveda College, Trivandrum 
Address  Sreenilayam, Vattathamara P.O, Kadakkal, Kollam

Kollam
KERALA
691536
India 
Phone  8590904006  
Fax    
Email  anjanasajikmr@gmail.com  
 
Source of Monetary or Material Support  
Nil 
 
Primary Sponsor  
Name  Anjana Saji 
Address  Sreenilayam, Vattathamara P.O, Kadakkal, Kollam Pin: 691536 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Anjana Saji  Government Ayurveda College Hospital, Trivandrum  Salakyathanthra department, OP, Room number 5
Thiruvananthapuram
KERALA 
08590904006

anjanasajikmr@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee (IEC), Govt. Ayurveda College, Trivandrum  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:H531||Subjective visual disturbances. Ayurveda Condition: TIMIRAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-pratimarSaH, प्रतिमर्श (Procedure Reference: Ashtanga Hrudayam Sutrasthanam, Procedure details: The Participant Will Be Trained By Demonstrating The Procedure. In The Morning, After Anjanam, The Participant Is Made To Lie Straight On His Back With Slight Lowering Of The Head Extending Arms And Legs. Taila Is Taken In Sterile Dropper Bottle And Made Lukewarm. 1 ml (Standardized 0.5 ml- 1 Bindu) Will Be Instilled In Each Nostril Alternately, Keeping The Other One Closed. Done Once Daily. )
(1) Medicine Name: Bhringaraja Thaila, Reference: Bhaishajya Rathnavali, Route: Nasal, Dosage Form: Taila, Dose: 1(ml), Frequency: od, Duration: 90 Days
2Intervention ArmDrugClassical(1) Medicine Name: Amalaka Rasayanam, Reference: Ashtanga Hrdayam Uttarasthanam, Route: Oral, Dosage Form: Avleha/Leha/Paka/Raskriya, Dose: 5(g), Frequency: od, Bhaishajya Kal: Adhobhakta, Duration: 90 Days, anupAna/sahapAna: No, Additional Information: -
3Intervention ArmDrugClassical(1) Medicine Name: Rasakadi Churnanjanam, Reference: Sharangadhara Samhitha, Route: Ocular, Dosage Form: Churna/ Powder, Dose: 125(mg), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 90 Days, anupAna/sahapAna: No, Additional Information: -Anjanam With Rasakadi Churnanjanam
4Intervention ArmDrugClassical(1) Medicine Name: Bhringaraja thaila, Reference: Bhaishajya ratnavali, Route: Nasal, Dosage Form: Taila, Dose: 1(ml), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 3 Months, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  50.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  Clinically Diagnosed Participants Of Dry-ARMD With Blurring Of Vision, Distorted Vision, Scotoma, And
Metamorphopsia. Participants Between The Age Group Of 50-70 Years Irrespective Of Gender, Religion, And Socioeconomic Status. Participants With Visual Acuity Of 6/9 to 6/60(Log mar 0.2-1.00).Participants With Written Informed Consent.  
 
ExclusionCriteria 
Details  A)Uncontrolled Hypertension Or Diabetes
B) Participants With Mature Cataract, High Myopia, Glaucoma, Other Retinal Degenerations
C) Participants With Systemic Illness Like Hypercholesteremia, Liver Disease, Renal Disease
D) Pigment Epithelium Detachment
E) Participants Who Are Not Co-operative
F) Participants With Any Other Macular Disease That Can Superimpose With ARMD
G) Participants Who Are Contraindicated For Prathimarsa Nasya
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Improvement In Visual Acuity - Log MAR chart  3 Months 
 
Secondary Outcome  
Outcome  TimePoints 
1. Amsler grid examination
2.Changes in the fundus
3.Changes in the OCT  
3 Months 
 
Target Sample Size   Total Sample Size="25"
Sample Size from India="25" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   30/06/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="1" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Age-related macular degeneration (ARMD) is a degenerative disorder affecting the macula, characterized by the presence of specific clinical findings, including drusen and RPE changes, in the absence of another disorder. Heredity, nutrition, smoking, hypertension, exposure to sunlight, hyperopia, and cataract particularly nuclear opacity have been proposed as risk factors in the pathogenesis of ARMD. Common visual complaints of Dry-ARMD are mild to moderate gradual loss of vision, distorted vision, seeing straight lines as wavy, bent, or fuzzy, and difficulty in near work due to central shadowing. Current treatments include Vitamin, antioxidant supplementation, intravitreal injection & photocoagulation. In Ayurveda, it can be taken as the saadam of darsanendriya resulting from the depletion of dhatus in old age. The gradual progressive painless loss of vision is the characteristic feature of pathology found in timira, kacha, linganasa. The pathogenesis of Dry-ARMD suggests the involvement of Tridoshas predominantly Kapha- Vata dosha. Thus, the basic treatment strategy adopted should be kapha vata samana, sodhana of excess meda kapha, Chakshushya and Rasayana. Anjanam & nasyam are mentioned for samanya thimira chikilsa in Ashtanga Hrdaya Uttara Sthana. Patients within the age group of 50 to 70 years diagnosed with Dry-ARMD will be selected based on inclusion criteria, attending OPD and IPD of Shalakyatantra, Govt. Ayurveda College, Thiruvananthapuram will be subjected to Rasakadi Churnanjanam, Bhringaraja Taila Prathimarsa nasya , and internal administration of Amalaka Rasayana for 3 months. Clinical evaluation and investigations will be done before the commencement of interventions and 3 months after treatment & follow-up will be done 1 month after that. Results will be statistically analyzed after the study by one-way ANOVA test.  
Close